Aridis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-…

Biotechnology
US, Los Gatos [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ARDS's Analysis
CIK: 1614067 CUSIP: 040334104 ISIN: US0403341045 LEI: - UEI: -
Secondary Listings
ARDS has no secondary listings inside our databases.